Skip to main content
Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
0.666
+0.013 (1.98%)
Nov 21, 2024, 11:15 AM EST - Market open

Predictive Oncology Revenue

Predictive Oncology had revenue of $345.69K in the quarter ending September 30, 2024, a decrease of -51.66%. This brings the company's revenue in the last twelve months to $1.48M, down -11.21% year-over-year. In the year 2023, Predictive Oncology had annual revenue of $1.78M with 18.24% growth.

Revenue (ttm)
$1.48M
Revenue Growth
-11.21%
P/S Ratio
2.11
Revenue / Employee
$42,406
Employees
35
Market Cap
4.44M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.78M274.63K18.24%
Dec 31, 20221.51M84.78K5.97%
Dec 31, 20211.42M168.41K13.45%
Dec 31, 20201.25M-159.29K-11.28%
Dec 31, 20191.41M-90.00-0.01%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Biofrontera 35.36M
Sonoma Pharmaceuticals 13.55M
Aptorum Group 431.38K
Cyclerion Therapeutics 194.00K
Silo Pharma 72.10K
Creative Medical Technology Holdings 11.00K
Revenue Rankings

POAI News

More News